[Pneumococcal vaccination. Assessment and prospects].
Licensed in 1977, the pneumococcal vaccine is sparsely used in France. By contrast most recent epidemiological studies demonstrated that this vaccine is capable to significantly lower the incidence of pneumococcal pneumonia in groups in which this infection is frequently life-threatening. The efficacity of such immunisation is high unless subject are immunocompromised. Recommendations for immunisation practices should be based these data and durely enforced.
Lafaix
C
C
Service des Maladies Infectieuses et Tropicales (Faculté de médecine de Créteil), Centre Hospitalier Intercommunal, Villeneuve Saint Georges.
D000368:Aged; D000369:Aged, 80 and over; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D011008:Pneumococcal Infections / Q000517:prevention & control; D013296:Streptococcus pneumoniae
D001428:Bacterial Vaccines
Vaccination pneumococcique. Bilan et perspectives.